Cannabis in Brazil

Last updated
Marcha da Maconha, Brasilia, 2013 Marcha da Maconha (Brasilia 2013).jpg
Marcha da Maconha, Brasilia, 2013
Marcha da Maconha, Rio de Janeiro, 2014 Marijuana march Rio de Janeiro 2014 May 10 Brazil marcha maconha.jpg
Marcha da Maconha, Rio de Janeiro, 2014

Cannabis in Brazil is illegal and criminalized, but possession and cultivation of personal amounts and for private use were de-penalized in 2006. [1] Use of cannabis medications is allowed for terminally ill patients or those who have exhausted other treatment options. It is also possible to import, manufacture and sell cannabis-based medicines. [2]

Contents

History

Cannabis was introduced to Brazil by the Portuguese colonists in the early 1800s. Their intent may have been to cultivate hemp fiber, but the slaves the Portuguese trafficked from Africa were familiar with cannabis and used it psychoactively, leading the Municipal Council of Rio de Janeiro in 1830 to prohibit bringing cannabis into the city, and punishing its use by any slave. [3]

Medical cannabis

Since 2015, cannabis medications greater than 0.2% THC can be prescribed for terminally ill patients or those who have exhausted other treatment options. Initially these medications could only be imported with special authorization from Anvisa, but in 2019 the rules were relaxed to allow pharmacy sales. Products less than 0.2% THC can be prescribed with less restriction. [4] [5]

In January 2017 Brazil issued its first license for a cannabis-based medicine, allowing sales of Mevatyl oral spray (internationally known as Sativex). [6]

In March 2020, the State of Pernambuco issued the first national license for the homemade planting of marijuana for medicinal purposes. [7]

Enforcement

Since 2006, public use of cannabis entails a warning, community service and education on the effects of drug use. The same measures apply to public use of any illegal drug. [1] However, there are reports[ failed verification ] of municipal guards applying extrajudicial punishment to civilian use of cannabis. [8]

Selling, transportation, and trafficking of drugs are considered criminal acts and are punished with 5 to 15 years in prison and a significant fine. [9]

Related Research Articles

<span class="mw-page-title-main">Tetrahydrocannabinol</span> Chemical compound

Tetrahydrocannabinol (THC) is the principal psychoactive constituent of cannabis and one of at least 113 total cannabinoids identified on the plant. Although the chemical formula for THC (C21H30O2) describes multiple isomers, the term THC usually refers to the Delta-9-THC isomer with chemical name (−)-trans9-tetrahydrocannabinol. THC is a terpenoid found in cannabis and, like many pharmacologically active phytochemicals, it is assumed to be involved in the plant's evolutionary adaptation against insect predation, ultraviolet light, and environmental stress. THC was first discovered and isolated by Israeli chemist Raphael Mechoulam in Israel in 1964. It was found that, when smoked, THC is absorbed into the bloodstream and travels to the brain, attaching itself to endocannabinoid receptors located in the cerebral cortex, cerebellum, and basal ganglia. These are the parts of the brain responsible for thinking, memory, pleasure, coordination and movement.

<span class="mw-page-title-main">Medical cannabis</span> Marijuana used medicinally

Medical cannabis, or medical marijuana (MMJ), is cannabis and cannabinoids that are prescribed by physicians for their patients. The use of cannabis as medicine has not been rigorously tested due to production and governmental restrictions, resulting in limited clinical research to define the safety and efficacy of using cannabis to treat diseases.

<span class="mw-page-title-main">Cannabidiol</span> Phytocannabinoid discovered in 1940

Cannabidiol (CBD) is a phytocannabinoid discovered in 1940. It is one of 113 identified cannabinoids in cannabis plants, along with tetrahydrocannabinol (THC), and accounts for up to 40% of the plant's extract. As of 2019, clinical research on CBD included studies related to anxiety, cognition, movement disorders, and pain, but there is insufficient high-quality evidence that cannabidiol is effective for these conditions. Nevertheless, CBD is a herbal dietary supplement promoted with unproven claims of particular therapeutic effects.

<span class="mw-page-title-main">Removal of cannabis from Schedule I of the Controlled Substances Act</span> Proposed changes to the legal status of cannabis in U.S. federal law

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act is a proposed legal and administrative change in cannabis-related law at the federal level. It has been proposed repeatedly since 1972. The category is the most tightly restricted category reserved for drugs that have "no currently accepted medical use."

<span class="mw-page-title-main">Cannabis (drug)</span> Psychoactive drug from the cannabis plant

Cannabis, also known as marijuana or weed among other names, is a psychoactive drug from the cannabis plant. Native to Central or South Asia, the cannabis plant has been used as a drug for both recreational and entheogenic purposes and in various traditional medicines for centuries. Tetrahydrocannabinol (THC) is the main psychoactive component of cannabis, which is one of the 483 known compounds in the plant, including at least 65 other cannabinoids, such as cannabidiol (CBD). Cannabis can be used by smoking, vaporizing, within food, or as an extract.

<span class="mw-page-title-main">Nabiximols</span> Specific cannabis extract

Nabiximols is a specific Cannabis extract that was approved in 2010 as a botanical drug in the United Kingdom. Nabiximols is sold as a mouth spray intended to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms of multiple sclerosis; it was developed by the UK company GW Pharmaceuticals. In 2019, it was proposed that following application of the spray, nabiximols is washed away from the oral mucosa by the saliva flow and ingested into the stomach, with subsequent absorption from the gastro-intestinal tract. Nabiximols is a combination drug standardized in composition, formulation, and dose. Its principal active components are the cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD). Each spray delivers a dose of 2.7 mg THC and 2.5 mg CBD.

<span class="mw-page-title-main">Legal history of cannabis in the United States</span>

In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.

<span class="mw-page-title-main">Drug liberalization</span> Process of reducing drug prohibition laws

Drug liberalization is a drug policy process of decriminalizing or legalizing the use or sale of prohibited drugs. Variations of drug liberalization include: drug legalization, drug re-legalization and drug decriminalization. Proponents of drug liberalization may favor a regulatory regime for the production, marketing, and distribution of some or all currently illegal drugs in a manner analogous to that for alcohol, caffeine and tobacco.

<span class="mw-page-title-main">Cannabis in the United States</span> Legality, use, culture, market and production of cannabis in the United States

The use, sale, and possession of cannabis containing over 0.3% THC by dry weight in the United States, despite laws in many states permitting it under various circumstances, is illegal under federal law. As a Schedule I drug under the federal Controlled Substances Act (CSA) of 1970, cannabis containing over 0.3% THC by dry weight is considered to have "no accepted medical use" and a high potential for abuse and physical or psychological dependence. Cannabis use is illegal for any reason, with the exception of FDA-approved research programs. However, individual states have enacted legislation permitting exemptions for various uses, including medical, industrial, and recreational use.

<span class="mw-page-title-main">Dronabinol</span> Generic name of Δ9-THC in medicine

The International Nonproprietary Name dronabinol, also known under the trade names Marinol, Syndros, Reduvo and Adversa, is a generic name for the molecule of delta-9-tetrahydrocannabinol in the pharmaceutical context. It has indications as an appetite stimulant, antiemetic, and sleep apnea reliever and is approved by the FDA as safe and effective for HIV/AIDS-induced anorexia and chemotherapy-induced nausea and vomiting only.

<span class="mw-page-title-main">Cannabis in Uruguay</span> Use of cannabis in Uruguay

Cannabis is legal in Uruguay, and is one of the most widely used drugs in the nation.

<span class="mw-page-title-main">Cannabis in Portugal</span> Use of cannabis in Portugal

Cannabis in Portugal is decriminalized, as a result of the decriminalization of all drugs in Portugal in 2001. Medical use of cannabis was legalized in 2018.

<span class="mw-page-title-main">Cannabis in Nevada</span> Legality of marijuana in Nevada

Cannabis in Nevada became legal for recreational use on January 1, 2017, following the passage of Question 2 on the 2016 ballot with 54% of the vote. The first licensed sales of recreational cannabis began on July 1, 2017.

<span class="mw-page-title-main">Cannabis in Texas</span> Overview of the use and culture of cannabis in Texas, U.S.

Cannabis in Texas is illegal for recreational use. Possession of up to two ounces is a class B misdemeanor, punishable by up to 180 days in prison and a fine of up to $2000. Several of the state's major municipalities have enacted reforms to apply lesser penalties or limit enforcement, however.

<span class="mw-page-title-main">Cannabis in Germany</span> Legality, use and culture of cannabis in Germany

Cannabis in Germany is legal for certain limited medical contexts, but illegal for recreational usage, though possession of minor amounts is not always prosecuted. As of 2022, approximately 4 million adults in Germany use cannabis.

<span class="mw-page-title-main">Cannabis in Israel</span>

Cannabis in Israel is allowed for specified medical usage, and is illegal but partially decriminalized for recreational use, with prosecution for home use and possession of 15 grams or less generally not enforced by the authorities. Public and cross-party political support for the complete decriminalization of cannabis increased in the 2010s with increasing usage for both medical and recreational purposes, and the establishment of a political party primarily devoted to this cause; on July 19, 2018, the Knesset approved a bill for decriminalization, although the supporters of recreational cannabis use insisted that this did not represent complete decriminalization. The law came into effect on April 1, 2019. On June 25, 2020, further legislation designed to decriminalize possession of up to 50 grams of cannabis began its passage through the Knesset.

Cannabis in Hungary is illegal. There is no distinction in Hungarian law between the dangers of use among illicit drugs. Heroin use has the same legal consequences as cannabis use. Hungarian law prohibits the distribution, and any use. However, the Penal code distinguishes the punishment between sale and personal use. 283. § (1) paragraph (a) states that "One cannot be punished for drug misuse; if a small, personal amount is produced, acquired, or in possession..." and continues to state that "... provided that before a final verdict is determined a verification is provided that continuous 6-month therapy has taken place" The law determines that a "personal quantity" is defined as 1 gram of active substance, therefore this equates to 12–100 grams of marijuana if calculated that marijuana contains 1–8% THC per unit mass. Possession of larger amounts can lead to a 5–10-year prison sentence.

Cannabis in Italy is currently legal for medical and industrial uses, although it is strictly regulated, while it is decriminalized for recreational uses. In particular, the possession of small amounts of marijuana for personal use is a civil infraction. The possible sanctions for possession vary from the issuing of a diffida to first offenders, that is an injunction not to use the drug again; to the temporary suspension of certain personal documents for repeat offenders. Conversely, the unauthorized sale of cannabis-related products is illegal and punishable with imprisonment, as is the unlicensed cultivation of cannabis, although recent court cases have effectively established the legality of cultivating small amounts of cannabis for exclusively personal use. The licensed cultivation of cannabis for medical and industrial purposes requires the use of certified seeds; however, there is no need for authorization to plant certified seeds with minimal levels of psychoactive compounds.

<span class="mw-page-title-main">Cannabis concentrate</span> Preparation of cannabis

Cannabis concentrate, also called marijuana concentrate, marijuana extract, or cannabis extract, is a tetrahydrocannabinol (THC) and/or cannabidiol (CBD) concentrated mass. Cannabis concentrates contain high THC levels that range from 40% to over 90%, stronger in THC content than high-grade marijuana, which normally measures around 20% THC levels.

<i>Pico da Neblina</i> (TV series) Brazilian TV series or program

Pico da Neblina is a Brazilian drama television series that premiered on HBO Brazil and Latin America on August 4, 2019. It depicts a scenario in which marijuana has been legalized in Brazil and following the story of a former drug dealer who needs to find a way to keep working.

References

  1. 1 2 Professor Anita Kalunta-Crumpton (28 June 2015). Pan-African Issues in Drugs and Drug Control: An International Perspective. Ashgate Publishing, Ltd. pp. 242–. ISBN   978-1-4724-2214-9.
  2. "Cannabis law and legislation in Brazil | CMS Expert Guides". cms.law. Retrieved 2022-07-08.
  3. Robert Clarke; Mark Merlin (1 September 2013). Cannabis: Evolution and Ethnobotany. University of California Press. pp. 182–. ISBN   978-0-520-95457-1.
  4. Ponieman, Natan (3 December 2019). "Brazil Regulates Sale Of Medical Marijuana Products". Benzinga. Retrieved 9 December 2019.
  5. "Brazil approves sale of medical cannabis in pharmacies". France 24. Agence France-Presse. 3 December 2019. Retrieved 9 December 2019.
  6. Federowski, Bruno (16 January 2017). "Brazil issues first license for sale of a cannabis-based drug". Reuters. Retrieved 11 February 2017.
  7. Diário de Pernambuco (2020-03-27). "Defensoria consegue primeira autorização definitiva para plantio de maconha em PE". Diário de Pernambuco. Retrieved 2020-03-27.
  8. Rezende, Graziela (5 March 2015). "Polícia analisa vídeo de adolescentes obrigados a comer maconha em MS (in portuguese)" [Police analyze video of teenagers forced to eat marijuana in MS] (in Portuguese). G1.
  9. Law 11.343, planalto.gov.br